Non-injectable Insulin Market Share, Trends & Forecast 2034

Q: Who are the key players in the market?

Novo Nordisk, Sanofi, and Eli Lilly are the key players. Read Report

Request Methodology

Non-injectable Insulin Market Outlook from 2024 to 2034

The global non-injectable insulin market is estimated to be worth US$ 1.7 billion in 2024. From 2024 to 2034, the market is projected to grow at a solid clip, registering a CAGR of 13.5%.

Attributes	Key Insights
Global Non-injectable Insulin Market Size (2024E)	US$ 1.7 billion
Market Value (2034F)	US$ 6.1 billion
Value-based CAGR (2024 to 2034)	13.5%

Growing prevalence of diabetes worldwide is surging the demand for non-injectable insulin as patients seek more comfort and convenience from the treatment. Cultural considerations and healthcare providers' willingness to try new treatments are set to impact patient preferences and adoption of non-injectable insulin.

In the pharmaceutical industry, the non-injectable insulin market provides easy and less challenging alternatives to traditional insulin injections, such as transdermal patches, oral insulin, and inhalable insulin. The market is growing due to innovative developments in drug delivery technology, which have resulted in more dependable and effective non-injectable insulin replacements.

Technological innovations in non-injectable insulin delivery devices are estimated to improve consumer experience and adherence, resulting in revenue growth and placing firms as competitive leaders. By 2034, the market is anticipated to reach US$ 6.1 billion.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Comparing Historical and Future Outlooks of the Non-injectable Insulin Market

From 2019 to 2023, the market has prolonged due to patient preferences for non-injectable products, fueled by advantages such as convenience, simplicity of administration, and less discomfort. The market grew at a CAGR of 17.0% between 2019 and 2023.

The advent of inhalable insulin was one of the prevalent changes in the non-injectable insulin industry. Exubera, the first inhalable insulin medication, received the United States Food & Drug Administration (FDA) approval in 2006. Afrezza's release, despite initial disappointment due to poor demand and concerns about its bulky inhaler, renewed interest in inhalable insulin, enhancing consumer acceptability.

The FDA's regulatory control, in particular, has had a key impact on the market. For non-injectable insulin solutions, strict regulatory criteria for safety, effectiveness, and quality standards have impacted clinical trial designs, product development, and market access. Although Afrezza is still the only FDA-approved inhaled insulin medication in the United States, several manufacturers have looked into creating comparable goods.

The demand for insulin is competitive. It is projected to spur innovation, enhance product offerings, and increase diabetes patients' treatment alternatives. By 2034, the market is set to surge at a CAGR of 13.5%, which is comparatively low from 2019 to 2023.

Insulin that is not injectable is now delivered more effectively because of developments in inhalation technology, including creating more accurate and effective inhaler devices. Sustained drug delivery methods, formulation optimization, and device design innovations are projected to boost market growth and enhance patient outcomes for non-injectable insulin treatment.

Key Non-injectable Insulin Market Trends

Leading companies are researching oral insulin formulations that can withstand digestive system conditions. They are potentially revolutionizing diabetes management by offering a comfortable, painless alternative to needles. Diabetes patients seek non-injectable insulin replacements due to needle phobia and daily hassles, pushing pharmaceutical companies to invest in unique products.

Regulatory bodies such as the FDA are evaluating and approving new insulin products, leading to a booming market. Pharmaceutical companies are collaborating with healthcare providers, IT companies, and research organizations to propel the development of insulin-delivery products.

Leading healthcare companies and professionals prioritize cost and accessibility to ensure all patients can access enhanced non-injectable solutions, fueling the market. The design process for insulin delivery systems is vital for diabetes patients, considering their preferences and input, thereby accelerating demand for non-injectable insulin.

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Comparative Analysis of Non-injectable Insulin Markets

The section below compares the global non-injectable insulin industry to the insulin pen market and the injectable drug delivery industry based on growth factors and key trends. This will help companies to get a better analysis of the market scenario.

The convenience of giving medication at home contributes to the augmented demand for injectable drug delivery systems in the market. The growing cases of diabetics, especially in Asian countries, have led to a surging use of injection pens.

Non-injectable Insulin Market:

Attributes	Non-injectable Insulin Market
CAGR (2024 to 2034)	13.5%
Market Opportunities for Non-injectable Insulin Products	Inhaled insulin formulations, a non-invasive alternative to injectable insulin, face challenges. But, improvements in formulation and delivery systems are set to lead to more viable options.
Trends in Non-injectable Insulin Delivery Methods	Developments in CGM systems and insulin pumps offer non-injectable insulin delivery options, improving blood sugar control and reducing the need for traditional injections.

Insulin Pen Market:

Attributes	Insulin Pen Market
CAGR (2024 to 2034)	6.5%
Growth Factor	Prefilled insulin pens provide convenience, reduce dosage errors, and improve patient adherence to treatment regimens by eliminating the need to fill insulin cartridges manually.
Opportunity	Insulin pen manufacturers are integrating digital health solutions like insulin calculators and data analytics to monitor patient adherence remotely, enhancing personalized treatment recommendations and improved outcomes.
Key Trends	Disposable insulin pens are gaining traction due to their convenience, reduced risk of contamination, and ease of maintenance, making them ideal for frequent travelers or people with busy lifestyles.

Injectable Drug Delivery Market:

Attributes	Injectable Drug Delivery Market
CAGR (2024 to 2034)	8.0%
Growth Factor	Injectable drug delivery devices have digital connectivity features for remote monitoring, enabling healthcare providers to track patient adherence, treatment outcomes, and real-time therapy adjustments.
Opportunity	Environmental sustainability fuels the development of eco-friendly injectable drug delivery systems, focusing on recyclable or biodegradable packaging alternatives to single-use plastics.
Key Trends	Chronic diseases demand biological drugs via injection, requiring specialized delivery systems for stability and effective dosing.

Geographic Growth Opportunities in Non-Injectable Insulin Market

The table below shows the estimated growth rates of the leading five nations. South Korea, Japan, and the United Kingdom are set to emerge as profitable markets for companies, recording CAGRs of 16.0%, 15.2%, and 14.6%, respectively, through 2034.

Countries	Projected CAGR (2024 to 2034)
United States	13.8%
United Kingdom	14.6%
China	14.2%
South Korea	16.0%
Japan	15.2%

The table below highlights key countries’ market revenues. The United States and China are forecast to remain the leading consumers of non-injectable insulin, with predicted valuations of US$ 1.1 billion and US$ 1.0 billion, respectively, in 2034.

Countries	Market Value (2034)
United States	US$ 1.1 billion
United Kingdom	US$ 243.2 million
China	US$ 1.0 billion
South Korea	US$ 395.6 million
Japan	US$ 665.7 million

Japan Emerging as a Key Market for Manufacturers

Japan's non-injectable insulin market is projected to reach a valuation of around US$ 665.7 million by 2034. Japan, with its high diabetes prevalence, urbanization, and growing healthcare infrastructure, is experiencing increased demand for innovative diabetes management solutions.

The growing awareness of insulin's convenience and reduced pain are projected to fuel the adoption of non-injectable insulin in Japan. Government initiatives and collaborations with pharmaceutical companies further promote market growth, positioning Japan as a leading player in the market.

The competitive landscape in Japan's pharmaceutical industry is projected to spur innovation and sales expansion in the non-injectable insulin market. Leading companies in Japan invest in research & development to enhance product formulas, delivery methods, and patient care services to set themselves apart.

Growing Urbanization and Healthcare Infrastructure Boosting the United States

Demand for non-injectable insulin is increasing in the United States, with a projected CAGR of 13.8% through 2034. MannKind Corporation's Afrezza is the primary insulin product for adults with diabetes, developed in the United States. It is a rapid-acting inhaled insulin available in powder form and regulated through an inhaler device.

Patient adoption and acceptability of non-injectable insulin treatments is determined by a number of factors, including cost, affordability, availability, efficacy, and safety. Campaigns for patient & healthcare professional education and awareness are planned to promote the benefits and increase adoption of non-injectable insulin therapy in the United States.

Escalating Research and Development Activities Propelling Demand in South Korea

The non-injectable insulin market is projected to increase in South Korea at a CAGR of 16.0% through 2034. South Korea is anticipated to undergo research & development activities to improve pharmaceutical compositions, delivery systems, and patient outcomes, fueling demand for non-injectable insulin. Collaborations among pharmaceutical firms, healthcare providers, and regulatory bodies are vital for pouring innovation and increasing access to non-injectable insulin therapy in South Korea.

Category-wise Insights

Pills stand atop the pile in the product type segment. The segment is anticipated to grow at a CAGR of 13.3% by 2034. Drug stores remain the predominant mode of distribution channel.

Segment	Value CAGR (2024 to 2034)
Pills (Product)	13.3%
Drug Stores (Distribution Channel)	13.1%

Pills Category to Generate Significant Revenue in the Industry

Oral insulin tablets are projected to rise at 13.3% CAGR through 2034. The marketing and distribution of insulin pills is dependent on permission from health authorities such as the European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA). Oral medicines are projected to improve insulin therapy adherence in individuals who find injections uncomfortable or unpleasant.

In January 2023, for instance, researchers at the UiT Norway's Arctic University published a paper in Nature Nanotechnology. It states that out of the 425 million people suffering from diabetes across the globe, nearly 75 million inject themselves with insulin. However, this can soon change as researchers have found a novel method to supply smart insulin. It can be taken by the patient as a capsule or with any other food item, including chocolates.

Drug Store Distribution Channel Gaining Wide Popularity among Consumers

Drug stores provide non-injectable medicines and specialized healthcare services, whereas specialty pharmacies focus on complicated medical conditions such as diabetes. Drug stores offer prescription counseling, adherence monitoring, and insurance help, making them important to ensure easy and convenient pharmaceutical access.

Competitive Landscape

A few leading companies and manufacturers dominate the market. They are launching new products worldwide to meet consumer demands and investing in research & development. Key companies also use several growth strategies to inflate their market reach and customer base, including mergers, acquisitions, partnerships, and collaborations.

For instance

In 2023, Oramed Pharmaceuticals, headquartered in the United States, and Hefei Tianhui Biotech formed a joint venture to promote oral drug products globally by using Oramed's oral insulin and protein delivery pipeline.
In 2023, NiedlFree Technologies, an India-based company, launched Ozulin, an oral insulin spray for type 1 and 2 diabetes patients. It is set to be available in India and globally by 2025 or 2026.
In 2022, Biocon, headquartered in India, acquired Viatris' biosimilar portfolio for US$ 3.335 billion, enhancing its biosimilar product offerings and increasing revenue generation.

Key Players in the Non-injectable Insulin Market

Novo Nordisk
Sanofi
Eli Lilly
MannKind Corporation
Biocon
Janssen Pharmaceuticals
Adocia
Oramed Pharmaceuticals
Dance Biopharm
Medtronic
Verily Life Sciences
Zafgen
Dance Biopharm
Senseonics
Bigfoot Biomedical

Key Coverage in the Research Report

Growth Prospects of Insulin Marketplace
Factors Pouring the Adoption of Non-injectable Products in Insulin
Challenges in the Insulin Industry
Innovations and Developments in Insulin Delivery Systems
Consumer Acceptance and Preferences for Non-injectable Insulin
Market Entry Strategies for Non-injectable Manufacturers
Future Outlook and Forecasts for the Insulin Market
Value Chain Analysis Non-injectable Insulin Industry
Demand-side Trends of the Non-injectable Insulin Industry
PESTLE and Porter's Analysis of the Insulin Market
Demand Analysis of Non-injectable Insulin Supplies

Market Segmentation for Non-injectable Insulin Products

By Product:

Pills
Sprays
Others

By Distribution Channel:

Hospital Pharmacies
Online Pharmacies
Drug Stores

By Region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

Frequently Asked Questions

How big is the non-injectable insulin market?

The industry is set to reach a valuation of US$ 1.7 billion in 2024.

What is the forecast for the market?

Demand for non-injectable insulin is set to rise at 13.5% CAGR by 2034.

What is the outlook for the non-injectable insulin industry?

The industry is projected to reach US$ 6.1 billion in 2034.

Who are the key players in the market?

Novo Nordisk, Sanofi, and Eli Lilly are the key players.

Which product form would lead the market?

The pills segment is estimated to hold a significant market share in 2024.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Product Life Cycle Analysis

3.5. Supply Chain Analysis

3.5.1. Supply Side Participants and their Roles

3.5.1.1. Manufacturer

3.5.1.2. Mid-Level Participants (Traders)

3.5.1.3. Wholesalers and Distributors

3.5.2. Value Added and Value Created at Node in the Supply Chain

3.5.3. List of Raw Material Suppliers

3.5.4. List of Existing and Potential Buyer’s

3.6. Investment Feasibility Matrix

3.7. Value Chain Analysis

3.7.1. Profit Margin Analysis

3.7.2. Wholesalers and Distributors

3.7.3. Retailers

3.8. PESTLE and Porter’s Analysis

3.9. Regulatory Landscape

3.9.1. By Key Regions

3.9.2. By Key Countries

3.10. Regional Parent Market Outlook

3.11. Production and Consumption Statistics

3.12. Import and Export Statistics

4. Global Market Analysis 2019 to 2023 and Forecast, 2024 to 2034

4.1. Historical Market Size Value (US$ million) & Volume (Units) Analysis, 2019 to 2023

4.2. Current and Future Market Size Value (US$ million) & Volume (Units) Projections, 2024 to 2034

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Product

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Product, 2019 to 2023

5.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Product, 2024 to 2034

5.3.1. Pills

5.3.2. Sprays

5.3.3. Others

5.4. Y-o-Y Growth Trend Analysis By Product, 2019 to 2023

5.5. Absolute $ Opportunity Analysis By Product, 2024 to 2034

6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Distribution Channel

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Distribution Channel, 2019 to 2023

6.3. Current and Future Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Distribution Channel, 2024 to 2034

6.3.1. Hospital Pharmacies

6.3.2. Online Pharmacies

6.3.3. Drug Stores

6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2019 to 2023

6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2024 to 2034

7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region

7.1. Introduction

7.2. Historical Market Size Value (US$ million) & Volume (Units) Analysis By Region, 2019 to 2023

7.3. Current Market Size Value (US$ million) & Volume (Units) Analysis and Forecast By Region, 2024 to 2034

7.3.1. North America

7.3.2. Latin America

7.3.3. Western Europe

7.3.4. Eastern Europe

7.3.5. South Asia and Pacific

7.3.6. East Asia

7.3.7. Middle East and Africa

7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

8.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

8.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

8.2.1. By Country

8.2.1.1. United States

8.2.1.2. Canada

8.2.2. By Product

8.2.3. By Distribution Channel

8.3. Market Attractiveness Analysis

8.3.1. By Country

8.3.2. By Product

8.3.3. By Distribution Channel

8.4. Key Takeaways

9. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

9.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

9.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

9.2.1. By Country

9.2.1.1. Brazil

9.2.1.2. Mexico

9.2.1.3. Rest of Latin America

9.2.2. By Product

9.2.3. By Distribution Channel

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Product

9.3.3. By Distribution Channel

9.4. Key Takeaways

10. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

10.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

10.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

10.2.1. By Country

10.2.1.1. Germany

10.2.1.2. United Kingdom

10.2.1.3. France

10.2.1.4. Spain

10.2.1.5. Italy

10.2.1.6. Rest of Western Europe

10.2.2. By Product

10.2.3. By Distribution Channel

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Product

10.3.3. By Distribution Channel

10.4. Key Takeaways

11. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

11.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

11.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

11.2.1. By Country

11.2.1.1. Poland

11.2.1.2. Russia

11.2.1.3. Czech Republic

11.2.1.4. Romania

11.2.1.5. Rest of Eastern Europe

11.2.2. By Product

11.2.3. By Distribution Channel

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Product

11.3.3. By Distribution Channel

11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

12.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

12.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

12.2.1. By Country

12.2.1.1. India

12.2.1.2. Bangladesh

12.2.1.3. Australia

12.2.1.4. New Zealand

12.2.1.5. Rest of South Asia and Pacific

12.2.2. By Product

12.2.3. By Distribution Channel

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Product

12.3.3. By Distribution Channel

12.4. Key Takeaways

13. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

13.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

13.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

13.2.1. By Country

13.2.1.1. China

13.2.1.2. Japan

13.2.1.3. South Korea

13.2.2. By Product

13.2.3. By Distribution Channel

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Product

13.3.3. By Distribution Channel

13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Country

14.1. Historical Market Size Value (US$ million) & Volume (Units) Trend Analysis By Market Taxonomy, 2019 to 2023

14.2. Market Size Value (US$ million) & Volume (Units) Forecast By Market Taxonomy, 2024 to 2034

14.2.1. By Country

14.2.1.1. GCC Countries

14.2.1.2. South Africa

14.2.1.3. Israel

14.2.1.4. Rest of Middle East and Africa

14.2.2. By Product

14.2.3. By Distribution Channel

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Product

14.3.3. By Distribution Channel

14.4. Key Takeaways

15. Key Countries Market Analysis

15.1. United States

15.1.1. Pricing Analysis

15.1.2. Market Share Analysis, 2024

15.1.2.1. By Product

15.1.2.2. By Distribution Channel

15.2. Canada

15.2.1. Pricing Analysis

15.2.2. Market Share Analysis, 2024

15.2.2.1. By Product

15.2.2.2. By Distribution Channel

15.3. Brazil

15.3.1. Pricing Analysis

15.3.2. Market Share Analysis, 2024

15.3.2.1. By Product

15.3.2.2. By Distribution Channel

15.4. Mexico

15.4.1. Pricing Analysis

15.4.2. Market Share Analysis, 2024

15.4.2.1. By Product

15.4.2.2. By Distribution Channel

15.5. Germany

15.5.1. Pricing Analysis

15.5.2. Market Share Analysis, 2024

15.5.2.1. By Product

15.5.2.2. By Distribution Channel

15.6. United Kingdom

15.6.1. Pricing Analysis

15.6.2. Market Share Analysis, 2024

15.6.2.1. By Product

15.6.2.2. By Distribution Channel

15.7. France

15.7.1. Pricing Analysis

15.7.2. Market Share Analysis, 2024

15.7.2.1. By Product

15.7.2.2. By Distribution Channel

15.8. Spain

15.8.1. Pricing Analysis

15.8.2. Market Share Analysis, 2024

15.8.2.1. By Product

15.8.2.2. By Distribution Channel

15.9. Italy

15.9.1. Pricing Analysis

15.9.2. Market Share Analysis, 2024

15.9.2.1. By Product

15.9.2.2. By Distribution Channel

15.10. Poland

15.10.1. Pricing Analysis

15.10.2. Market Share Analysis, 2024

15.10.2.1. By Product

15.10.2.2. By Distribution Channel

15.11. Russia

15.11.1. Pricing Analysis

15.11.2. Market Share Analysis, 2024

15.11.2.1. By Product

15.11.2.2. By Distribution Channel

15.12. Czech Republic

15.12.1. Pricing Analysis

15.12.2. Market Share Analysis, 2024

15.12.2.1. By Product

15.12.2.2. By Distribution Channel

15.13. Romania

15.13.1. Pricing Analysis

15.13.2. Market Share Analysis, 2024

15.13.2.1. By Product

15.13.2.2. By Distribution Channel

15.14. India

15.14.1. Pricing Analysis

15.14.2. Market Share Analysis, 2024

15.14.2.1. By Product

15.14.2.2. By Distribution Channel

15.15. Bangladesh

15.15.1. Pricing Analysis

15.15.2. Market Share Analysis, 2024

15.15.2.1. By Product

15.15.2.2. By Distribution Channel

15.16. Australia

15.16.1. Pricing Analysis

15.16.2. Market Share Analysis, 2024

15.16.2.1. By Product

15.16.2.2. By Distribution Channel

15.17. New Zealand

15.17.1. Pricing Analysis

15.17.2. Market Share Analysis, 2024

15.17.2.1. By Product

15.17.2.2. By Distribution Channel

15.18. China

15.18.1. Pricing Analysis

15.18.2. Market Share Analysis, 2024

15.18.2.1. By Product

15.18.2.2. By Distribution Channel

15.19. Japan

15.19.1. Pricing Analysis

15.19.2. Market Share Analysis, 2024

15.19.2.1. By Product

15.19.2.2. By Distribution Channel

15.20. South Korea

15.20.1. Pricing Analysis

15.20.2. Market Share Analysis, 2024

15.20.2.1. By Product

15.20.2.2. By Distribution Channel

15.21. GCC Countries

15.21.1. Pricing Analysis

15.21.2. Market Share Analysis, 2024

15.21.2.1. By Product

15.21.2.2. By Distribution Channel

15.22. South Africa

15.22.1. Pricing Analysis

15.22.2. Market Share Analysis, 2024

15.22.2.1. By Product

15.22.2.2. By Distribution Channel

15.23. Israel

15.23.1. Pricing Analysis

15.23.2. Market Share Analysis, 2024

15.23.2.1. By Product

15.23.2.2. By Distribution Channel

16. Market Structure Analysis

16.1. Competition Dashboard

16.2. Competition Benchmarking

16.3. Market Share Analysis of Top Players

16.3.1. By Regional

16.3.2. By Product

16.3.3. By Distribution Channel

17. Competition Analysis

17.1. Competition Deep Dive

17.1.1. Novo Nordisk

17.1.1.1. Overview

17.1.1.2. Product Portfolio

17.1.1.3. Profitability by Market Segments

17.1.1.4. Sales Footprint

17.1.1.5. Strategy Overview

17.1.1.5.1. Marketing Strategy

17.1.1.5.2. Product Strategy

17.1.1.5.3. Channel Strategy

17.1.2. Sanofi

17.1.2.1. Overview

17.1.2.2. Product Portfolio

17.1.2.3. Profitability by Market Segments

17.1.2.4. Sales Footprint

17.1.2.5. Strategy Overview

17.1.2.5.1. Marketing Strategy

17.1.2.5.2. Product Strategy

17.1.2.5.3. Channel Strategy

17.1.3. Eli Lilly

17.1.3.1. Overview

17.1.3.2. Product Portfolio

17.1.3.3. Profitability by Market Segments

17.1.3.4. Sales Footprint

17.1.3.5. Strategy Overview

17.1.3.5.1. Marketing Strategy

17.1.3.5.2. Product Strategy

17.1.3.5.3. Channel Strategy

17.1.4. MannKind Corporation

17.1.4.1. Overview

17.1.4.2. Product Portfolio

17.1.4.3. Profitability by Market Segments

17.1.4.4. Sales Footprint

17.1.4.5. Strategy Overview

17.1.4.5.1. Marketing Strategy

17.1.4.5.2. Product Strategy

17.1.4.5.3. Channel Strategy

17.1.5. Biocon

17.1.5.1. Overview

17.1.5.2. Product Portfolio

17.1.5.3. Profitability by Market Segments

17.1.5.4. Sales Footprint

17.1.5.5. Strategy Overview

17.1.5.5.1. Marketing Strategy

17.1.5.5.2. Product Strategy

17.1.5.5.3. Channel Strategy

17.1.6. Janssen Pharmaceuticals

17.1.6.1. Overview

17.1.6.2. Product Portfolio

17.1.6.3. Profitability by Market Segments

17.1.6.4. Sales Footprint

17.1.6.5. Strategy Overview

17.1.6.5.1. Marketing Strategy

17.1.6.5.2. Product Strategy

17.1.6.5.3. Channel Strategy

17.1.7. Adocia

17.1.7.1. Overview

17.1.7.2. Product Portfolio

17.1.7.3. Profitability by Market Segments

17.1.7.4. Sales Footprint

17.1.7.5. Strategy Overview

17.1.7.5.1. Marketing Strategy

17.1.7.5.2. Product Strategy

17.1.7.5.3. Channel Strategy

17.1.8. Oramed Pharmaceuticals

17.1.8.1. Overview

17.1.8.2. Product Portfolio

17.1.8.3. Profitability by Market Segments

17.1.8.4. Sales Footprint

17.1.8.5. Strategy Overview

17.1.8.5.1. Marketing Strategy

17.1.8.5.2. Product Strategy

17.1.8.5.3. Channel Strategy

17.1.9. Dance Biopharm

17.1.9.1. Overview

17.1.9.2. Product Portfolio

17.1.9.3. Profitability by Market Segments

17.1.9.4. Sales Footprint

17.1.9.5. Strategy Overview

17.1.9.5.1. Marketing Strategy

17.1.9.5.2. Product Strategy

17.1.9.5.3. Channel Strategy

17.1.10. Medtronic

17.1.10.1. Overview

17.1.10.2. Product Portfolio

17.1.10.3. Profitability by Market Segments

17.1.10.4. Sales Footprint

17.1.10.5. Strategy Overview

17.1.10.5.1. Marketing Strategy

17.1.10.5.2. Product Strategy

17.1.10.5.3. Channel Strategy

17.1.11. Verily Life Sciences

17.1.11.1. Overview

17.1.11.2. Product Portfolio

17.1.11.3. Profitability by Market Segments

17.1.11.4. Sales Footprint

17.1.11.5. Strategy Overview

17.1.11.5.1. Marketing Strategy

17.1.11.5.2. Product Strategy

17.1.11.5.3. Channel Strategy

17.1.12. Zafgen

17.1.12.1. Overview

17.1.12.2. Product Portfolio

17.1.12.3. Profitability by Market Segments

17.1.12.4. Sales Footprint

17.1.12.5. Strategy Overview

17.1.12.5.1. Marketing Strategy

17.1.12.5.2. Product Strategy

17.1.12.5.3. Channel Strategy

17.1.13. Dance Biopharm

17.1.13.1. Overview

17.1.13.2. Product Portfolio

17.1.13.3. Profitability by Market Segments

17.1.13.4. Sales Footprint

17.1.13.5. Strategy Overview

17.1.13.5.1. Marketing Strategy

17.1.13.5.2. Product Strategy

17.1.13.5.3. Channel Strategy

17.1.14. Senseonics

17.1.14.1. Overview

17.1.14.2. Product Portfolio

17.1.14.3. Profitability by Market Segments

17.1.14.4. Sales Footprint

17.1.14.5. Strategy Overview

17.1.14.5.1. Marketing Strategy

17.1.14.5.2. Product Strategy

17.1.14.5.3. Channel Strategy

17.1.15. Bigfoot Biomedical

17.1.15.1. Overview

17.1.15.2. Product Portfolio

17.1.15.3. Profitability by Market Segments

17.1.15.4. Sales Footprint

17.1.15.5. Strategy Overview

17.1.15.5.1. Marketing Strategy

17.1.15.5.2. Product Strategy

17.1.15.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

List of Tables

Table 1: Global Market Value (US$ million) Forecast by Region, 2019 to 2034

Table 2: Global Market Volume (Units) Forecast by Region, 2019 to 2034

Table 3: Global Market Value (US$ million) Forecast by Product, 2019 to 2034

Table 4: Global Market Volume (Units) Forecast by Product, 2019 to 2034

Table 5: Global Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034

Table 6: Global Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034

Table 7: North America Market Value (US$ million) Forecast by Country, 2019 to 2034

Table 8: North America Market Volume (Units) Forecast by Country, 2019 to 2034

Table 9: North America Market Value (US$ million) Forecast by Product, 2019 to 2034

Table 10: North America Market Volume (Units) Forecast by Product, 2019 to 2034

Table 11: North America Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034

Table 12: North America Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034

Table 13: Latin America Market Value (US$ million) Forecast by Country, 2019 to 2034

Table 14: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034

Table 15: Latin America Market Value (US$ million) Forecast by Product, 2019 to 2034

Table 16: Latin America Market Volume (Units) Forecast by Product, 2019 to 2034

Table 17: Latin America Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034

Table 18: Latin America Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034

Table 19: Western Europe Market Value (US$ million) Forecast by Country, 2019 to 2034

Table 20: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034

Table 21: Western Europe Market Value (US$ million) Forecast by Product, 2019 to 2034

Table 22: Western Europe Market Volume (Units) Forecast by Product, 2019 to 2034

Table 23: Western Europe Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034

Table 24: Western Europe Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034

Table 25: Eastern Europe Market Value (US$ million) Forecast by Country, 2019 to 2034

Table 26: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034

Table 27: Eastern Europe Market Value (US$ million) Forecast by Product, 2019 to 2034

Table 28: Eastern Europe Market Volume (Units) Forecast by Product, 2019 to 2034

Table 29: Eastern Europe Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034

Table 30: Eastern Europe Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034

Table 31: South Asia and Pacific Market Value (US$ million) Forecast by Country, 2019 to 2034

Table 32: South Asia and Pacific Market Volume (Units) Forecast by Country, 2019 to 2034

Table 33: South Asia and Pacific Market Value (US$ million) Forecast by Product, 2019 to 2034

Table 34: South Asia and Pacific Market Volume (Units) Forecast by Product, 2019 to 2034

Table 35: South Asia and Pacific Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034

Table 36: South Asia and Pacific Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034

Table 37: East Asia Market Value (US$ million) Forecast by Country, 2019 to 2034

Table 38: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034

Table 39: East Asia Market Value (US$ million) Forecast by Product, 2019 to 2034

Table 40: East Asia Market Volume (Units) Forecast by Product, 2019 to 2034

Table 41: East Asia Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034

Table 42: East Asia Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034

Table 43: Middle East and Africa Market Value (US$ million) Forecast by Country, 2019 to 2034

Table 44: Middle East and Africa Market Volume (Units) Forecast by Country, 2019 to 2034

Table 45: Middle East and Africa Market Value (US$ million) Forecast by Product, 2019 to 2034

Table 46: Middle East and Africa Market Volume (Units) Forecast by Product, 2019 to 2034

Table 47: Middle East and Africa Market Value (US$ million) Forecast by Distribution Channel, 2019 to 2034

Table 48: Middle East and Africa Market Volume (Units) Forecast by Distribution Channel, 2019 to 2034

List of Charts

Figure 1: Global Market Value (US$ million) by Product, 2024 to 2034

Figure 2: Global Market Value (US$ million) by Distribution Channel, 2024 to 2034

Figure 3: Global Market Value (US$ million) by Region, 2024 to 2034

Figure 4: Global Market Value (US$ million) Analysis by Region, 2019 to 2034

Figure 5: Global Market Volume (Units) Analysis by Region, 2019 to 2034

Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2024 to 2034

Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034

Figure 8: Global Market Value (US$ million) Analysis by Product, 2019 to 2034

Figure 9: Global Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 10: Global Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 11: Global Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 12: Global Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034

Figure 13: Global Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034

Figure 14: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 15: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 16: Global Market Attractiveness by Product, 2024 to 2034

Figure 17: Global Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 18: Global Market Attractiveness by Region, 2024 to 2034

Figure 19: North America Market Value (US$ million) by Product, 2024 to 2034

Figure 20: North America Market Value (US$ million) by Distribution Channel, 2024 to 2034

Figure 21: North America Market Value (US$ million) by Country, 2024 to 2034

Figure 22: North America Market Value (US$ million) Analysis by Country, 2019 to 2034

Figure 23: North America Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 24: North America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 25: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 26: North America Market Value (US$ million) Analysis by Product, 2019 to 2034

Figure 27: North America Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 28: North America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 29: North America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 30: North America Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034

Figure 31: North America Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034

Figure 32: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 33: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 34: North America Market Attractiveness by Product, 2024 to 2034

Figure 35: North America Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 36: North America Market Attractiveness by Country, 2024 to 2034

Figure 37: Latin America Market Value (US$ million) by Product, 2024 to 2034

Figure 38: Latin America Market Value (US$ million) by Distribution Channel, 2024 to 2034

Figure 39: Latin America Market Value (US$ million) by Country, 2024 to 2034

Figure 40: Latin America Market Value (US$ million) Analysis by Country, 2019 to 2034

Figure 41: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 42: Latin America Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 43: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 44: Latin America Market Value (US$ million) Analysis by Product, 2019 to 2034

Figure 45: Latin America Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 46: Latin America Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 48: Latin America Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034

Figure 49: Latin America Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034

Figure 50: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 51: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 52: Latin America Market Attractiveness by Product, 2024 to 2034

Figure 53: Latin America Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 54: Latin America Market Attractiveness by Country, 2024 to 2034

Figure 55: Western Europe Market Value (US$ million) by Product, 2024 to 2034

Figure 56: Western Europe Market Value (US$ million) by Distribution Channel, 2024 to 2034

Figure 57: Western Europe Market Value (US$ million) by Country, 2024 to 2034

Figure 58: Western Europe Market Value (US$ million) Analysis by Country, 2019 to 2034

Figure 59: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 60: Western Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 61: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 62: Western Europe Market Value (US$ million) Analysis by Product, 2019 to 2034

Figure 63: Western Europe Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 64: Western Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 65: Western Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 66: Western Europe Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034

Figure 67: Western Europe Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034

Figure 68: Western Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 69: Western Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 70: Western Europe Market Attractiveness by Product, 2024 to 2034

Figure 71: Western Europe Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 72: Western Europe Market Attractiveness by Country, 2024 to 2034

Figure 73: Eastern Europe Market Value (US$ million) by Product, 2024 to 2034

Figure 74: Eastern Europe Market Value (US$ million) by Distribution Channel, 2024 to 2034

Figure 75: Eastern Europe Market Value (US$ million) by Country, 2024 to 2034

Figure 76: Eastern Europe Market Value (US$ million) Analysis by Country, 2019 to 2034

Figure 77: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 78: Eastern Europe Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 79: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 80: Eastern Europe Market Value (US$ million) Analysis by Product, 2019 to 2034

Figure 81: Eastern Europe Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 82: Eastern Europe Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 83: Eastern Europe Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 84: Eastern Europe Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034

Figure 85: Eastern Europe Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034

Figure 86: Eastern Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 87: Eastern Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 88: Eastern Europe Market Attractiveness by Product, 2024 to 2034

Figure 89: Eastern Europe Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 90: Eastern Europe Market Attractiveness by Country, 2024 to 2034

Figure 91: South Asia and Pacific Market Value (US$ million) by Product, 2024 to 2034

Figure 92: South Asia and Pacific Market Value (US$ million) by Distribution Channel, 2024 to 2034

Figure 93: South Asia and Pacific Market Value (US$ million) by Country, 2024 to 2034

Figure 94: South Asia and Pacific Market Value (US$ million) Analysis by Country, 2019 to 2034

Figure 95: South Asia and Pacific Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 96: South Asia and Pacific Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 97: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 98: South Asia and Pacific Market Value (US$ million) Analysis by Product, 2019 to 2034

Figure 99: South Asia and Pacific Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 100: South Asia and Pacific Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 101: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 102: South Asia and Pacific Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034

Figure 103: South Asia and Pacific Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034

Figure 104: South Asia and Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 105: South Asia and Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 106: South Asia and Pacific Market Attractiveness by Product, 2024 to 2034

Figure 107: South Asia and Pacific Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 108: South Asia and Pacific Market Attractiveness by Country, 2024 to 2034

Figure 109: East Asia Market Value (US$ million) by Product, 2024 to 2034

Figure 110: East Asia Market Value (US$ million) by Distribution Channel, 2024 to 2034

Figure 111: East Asia Market Value (US$ million) by Country, 2024 to 2034

Figure 112: East Asia Market Value (US$ million) Analysis by Country, 2019 to 2034

Figure 113: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 114: East Asia Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 115: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 116: East Asia Market Value (US$ million) Analysis by Product, 2019 to 2034

Figure 117: East Asia Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 118: East Asia Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 119: East Asia Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 120: East Asia Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034

Figure 121: East Asia Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034

Figure 122: East Asia Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 123: East Asia Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 124: East Asia Market Attractiveness by Product, 2024 to 2034

Figure 125: East Asia Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 126: East Asia Market Attractiveness by Country, 2024 to 2034

Figure 127: Middle East and Africa Market Value (US$ million) by Product, 2024 to 2034

Figure 128: Middle East and Africa Market Value (US$ million) by Distribution Channel, 2024 to 2034

Figure 129: Middle East and Africa Market Value (US$ million) by Country, 2024 to 2034

Figure 130: Middle East and Africa Market Value (US$ million) Analysis by Country, 2019 to 2034

Figure 131: Middle East and Africa Market Volume (Units) Analysis by Country, 2019 to 2034

Figure 132: Middle East and Africa Market Value Share (%) and BPS Analysis by Country, 2024 to 2034

Figure 133: Middle East and Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034

Figure 134: Middle East and Africa Market Value (US$ million) Analysis by Product, 2019 to 2034

Figure 135: Middle East and Africa Market Volume (Units) Analysis by Product, 2019 to 2034

Figure 136: Middle East and Africa Market Value Share (%) and BPS Analysis by Product, 2024 to 2034

Figure 137: Middle East and Africa Market Y-o-Y Growth (%) Projections by Product, 2024 to 2034

Figure 138: Middle East and Africa Market Value (US$ million) Analysis by Distribution Channel, 2019 to 2034

Figure 139: Middle East and Africa Market Volume (Units) Analysis by Distribution Channel, 2019 to 2034

Figure 140: Middle East and Africa Market Value Share (%) and BPS Analysis by Distribution Channel, 2024 to 2034

Figure 141: Middle East and Africa Market Y-o-Y Growth (%) Projections by Distribution Channel, 2024 to 2034

Figure 142: Middle East and Africa Market Attractiveness by Product, 2024 to 2034

Figure 143: Middle East and Africa Market Attractiveness by Distribution Channel, 2024 to 2034

Figure 144: Middle East and Africa Market Attractiveness by Country, 2024 to 2034

November 2023

REP-GB-18402

April 2024

250 pages

Healthcare

Sabyasachi Ghosh

Book Now

Clients

Customize This Research

Quick Contact

Chat on Whatsapp + 44 (0) 20 8123 9659 + 1 347 918 3531 Contact By Email

- Trust FMI -

- Member of -

Greater New York Chamber of Commerce

- Awarded by -

BRONZE STEVIE® Award

20th annual IBAs

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

- Recognized by -

Non-injectable Insulin Market

Non-injectable Insulin Market Analysis Based on Pills and Spray Products from 2024 to 2034